HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1352152Generated: October 25, 2026
4-Fluorobenzylamine → N1-(4-Fluorobenzyl)-N4-(1H-5-indazolyl)-1,4-cyclohexanediamine
https://huagongshe.com/reaction/1352152
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Fluorobenzylamine | HCID 67326 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | 4-(1H-5-Indazolylamino)-1-cyclohexanone | HCID 17838271 | — |
| Reactant | Hydrochloride methanol | HCID 21893726 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | N1-(4-Fluorobenzyl)-N4-(1H-5-indazolyl)-1,4-cyclohexanediamine | HCID 17838166 | 23.8% |
Reaction Steps
4-(1H-5-Indazolylamino)-1-cyclohexanone (intermediate 3) (57 mg) and 4-fluorobenzylamine (70 mg) were dissolved in methanol (1 ml), and sodium triacetoxyborohydride (105 mg) was added by portions to the solution at room temperature. The reaction mixture was stirred at room temperature for 18 hr. Hydrochloric acid-methanol was then added thereto, and the mixture was stirred and was then concentrated. The residue was purified by HPLC [0.5% aqueous trifluoroacetic acid solution/acetonitrile]. A saturated aqueous sodium hydrogencarbonate solution (2 ml) was then added to fractions containing respective compounds, followed by extraction with chloroform-propanol (3/1). The organic layers were dried over anhydrous sodium sulfate, and the solvent was removed by distillation under the reduced pressure to give an anti-form compound (20 mg) and a syn-form compound (12 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07217722B2 |
|---|
| Source dataset | uspto-grants-2007_05 |
|---|
| ORD ID | ord-5f422201ad85448398f46459fe0c3b1b |
|---|
| Source note | uspto-grants-2007_05 |
|---|